Imatinib mesylate for aggressive systemic mastocytosis with long bone osteolysis - 28/07/11
Doi : 10.1016/j.jaad.2009.11.034
Anja Gunda Jung, MD a, b, ⁎ 
, Hans-Peter Horny, MD c, Karl Sotlar, MD d, Tobias Overbeck, MD e, Michael Peter Schön, MD a, Undine Lippert, MD a, b
, Hans-Peter Horny, MD c, Karl Sotlar, MD d, Tobias Overbeck, MD e, Michael Peter Schön, MD a, Undine Lippert, MD a, b a Department of Dermatology and Venereology, Georg-August-University of Goettingen, Goettingen, Germany
b Department of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany
c Institute of Pathology, Ansbach, Germany
d Institute of Pathology, Ludwig-Maximilians-University of Munich, Munich, Germany
e Department of Hematology and Oncology, Georg-August-University of Goettingen, Goettingen, Germany
Correspondence to: Anja Gunda Jung, MD, Department of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Auenweg 38, 06847 Dessau, Germany.| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2009
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 65 - N° 1
P. 224-226 - juillet 2011 Retour au numéro
Article précédent
- Ectopic facial Hailey-Hailey disease
- Zeina A.W. Dajani, Diya F. Mutasim
- Newly diagnosed Ehlers–Danlos syndrome in an adult with elastosis perforans serpiginosa
- Jasmine Ahmadi, Jennifer N. Choi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?